TomTom NV (TOM2):企業の財務・戦略的SWOT分析

◆英語タイトル:TomTom NV (TOM2) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8012479
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月5日
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:技術・通信
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

TomTom NV (TOM2) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

TomTom NV (TomTom) designs and develops navigation and mapping products. The company offers navigation and digital mapping devices, and traffic and software for car manufacturers; and GPS sports watches, fleet management solutions, and location-based products for runners, cyclists, and swimmers. Tom Tom offers cloud-based products which allow developers to create location-enabled applications for governments and businesses. TomTom also provides vehicle telematics, fleet management, and connected car services for enhancing vehicle performance, save fuel and increase overall fleet efficiency. The company caters its products and services to business and government, automotive, and telematics sectors. It operates over 58 offices in 35 countries globally. TomTom is headquartered in Amsterdam, the Netherlands.

TomTom NV Key Recent Developments

Oct 20,2017: TomTom reports third quarter 2017 results
Sep 29,2017: Bernd Leukert appointed as supervisory board member of TomTom
Sep 29,2017: Bernd Leukert appointed as supervisory board member of TomTom
Sep 29,2017: TomTom cuts 136 jobs as it shifts away from consumer wearables
Sep 12,2017: TomTom Gets Set for the Future of Driving at IAA Frankfurt 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
TomTom NV – Key Facts 5
TomTom NV – Key Employees 6
TomTom NV – Key Employee Biographies 7
TomTom NV – Key Operational Employees 8
TomTom NV – Major Products and Services 9
TomTom NV – History 10
TomTom NV – Company Statement 18
TomTom NV – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Section 2 – Company Analysis 22
TomTom NV – Business Description 22
TomTom NV – Corporate Strategy 23
TomTom NV – SWOT Analysis 24
SWOT Analysis – Overview 24
TomTom NV – Strengths 24
TomTom NV – Weaknesses 25
TomTom NV – Opportunities 26
TomTom NV – Threats 27
TomTom NV – Key Competitors 28
Section 3 – Company Financial Ratios 29
Financial Ratios – Capital Market Ratios 29
Financial Ratios – Annual Ratios 30
Performance Chart 33
Financial Performance 33
Financial Ratios – Interim Ratios 34
Financial Ratios – Ratio Charts 35
TomTom NV, Recent Deals Summary 36
Section 4 – Company’s Recent Developments 37
Oct 20, 2017: TomTom reports third quarter 2017 results 37
Sep 29, 2017: Bernd Leukert appointed as supervisory board member of TomTom 38
Sep 29, 2017: Bernd Leukert appointed as supervisory board member of TomTom 39
Sep 12, 2017: TomTom Gets Set for the Future of Driving at IAA Frankfurt 2017 40
Jul 19, 2017: TomTom reports Q2 2017 results 41
Jul 19, 2017: TomTom reports net loss for Q2, provides guidance for 2017 43
Feb 14, 2017: TomTom receives Automotive Innovation Award for On-Street Parking service 44
Feb 09, 2017: TomTom announces changes to its Supervisory Board 45
Feb 08, 2017: TomTom reports net loss for Q4 46
Oct 20, 2016: TomTom reports third quarter 2016 results 47
Section 5 – Appendix 48
Methodology 48
Ratio Definitions 48
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
TomTom NV, Key Facts 5
TomTom NV, Key Employees 6
TomTom NV, Key Employee Biographies 7
TomTom NV, Key Operational Employees 8
TomTom NV, Major Products and Services 9
TomTom NV, History 10
TomTom NV, Other Locations 20
TomTom NV, Subsidiaries 21
TomTom NV, Key Competitors 28
TomTom NV, Ratios based on current share price 29
TomTom NV, Annual Ratios 30
TomTom NV, Annual Ratios (Cont...1) 31
TomTom NV, Annual Ratios (Cont...2) 32
TomTom NV, Interim Ratios 34
TomTom NV, Recent Deals Summary 36
Currency Codes 48
Capital Market Ratios 48
Equity Ratios 49
Profitability Ratios 49
Cost Ratios 50
Liquidity Ratios 50
Leverage Ratios 51
Efficiency Ratios 51

★海外企業調査レポート[TomTom NV (TOM2):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ESSA Pharma Inc (EPI):企業の財務・戦略的SWOT分析
    Summary Essa Pharma Inc (Essa Pharma) is a drug developer that offers oncology therapeutics. The company develops EPI-506, disrupts androgen receptor transcriptional activity through selectively blocking the N-terminal domain of the AR. It also conducts research on prostate cancer and the androgen r …
  • Taisho Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Taisho Pharmaceutical Co Ltd (Taisho), a subsidiary of Taisho Pharmaceutical Holdings Co Ltd is a pharmaceutical company that develops, manufactures and markets a range of prescription pharmaceutical and self-medication drugs. The company offers products that include lipovitan D, riup, clari …
  • Probiodrug AG (PBD)-製薬・医療分野:企業M&A・提携分析
    Summary Probiodrug AG (Probiodrug) is a biopharmaceutical company that conducts research and development of therapies for Alzheimer’s disease. The company provides three pipeline drug candidates such as PQ912, PBD-C06 and PQ1565. Its PQ912 drug candidate is a small molecule glutaminyl cyclase (QC) i …
  • Acerinox Group:企業の戦略・SWOT・財務情報
    Acerinox Group - Strategy, SWOT and Corporate Finance Report Summary Acerinox Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sareum Holdings Plc (SAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Sareum Holdings Plc (Sareum) is a drug discovery and development company that produces targeted small molecule therapeutics for treating cancer and autoimmune diseases. The drug research programs of the company are based on its proprietary drug discovery technology, Sareum Kinase Inhibitor L …
  • GenomeDx Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary GenomeDx Biosciences Inc (GenomeDx) is a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers. The company offers decipher prostate cancer classifier, a transformative genomic test that provides an assessment of tumor agg …
  • Immune Therapeutics Inc (IMUN):製薬・医療:M&Aディール及び事業提携情報
    Summary Immune Therapeutics Inc (IMUN), formerly pH Environmental Inc, is a specialty pharmaceutical company that discovers, develops and commercializes patented therapies and technology such as Lodonal, LDN, CAR-T and MENK. The company’s patented therapies are focused on the activation and re-balan …
  • Mesoblast Ltd (MSB):製薬・医療:M&Aディール及び事業提携情報
    Summary Mesoblast Ltd (Mesoblast) is a regenerative medicine company, which develops regenerative cell-based products. Its pipeline product candidates include MPC-150-IM, which is under development for the treatment of chronic congestive heart failure; MSC-100-IV, for the treatment of acute graft ve …
  • Petroleum Geo-Services ASA (PGS):石油・ガス:M&Aディール及び事業提携情報
    Summary Petroleum Geo-Services ASA (PGS) is a marine geophysical company. The company provides a wide range of products including seismic and electromagnetic services, data acquisition, processing, reservoir analysis/interpretation and MultiClient library data. Its MultiClient data library is among …
  • Natural Alternatives International Inc (NAII):企業の財務・戦略的SWOT分析
    Summary Natural Alternatives International Inc (NAI) is a formulator and manufacturer of customized nutritional supplements. It manufactures and distributes the only patented beta-alanine supplement CarnoSyn. It offers services such as science-based product formulation, raw material acquisition and …
  • Toagosei Co., Ltd.:企業の戦略・SWOT・財務分析
    Toagosei Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Toagosei Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Noble Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Noble Life Sciences Inc (Noble Life Sciences) is a contract research organization that offers vaccines, drugs, and medical device development services. The company provides preclinical services such as disease and animal models, drug pharmacology and exploratory toxicology, analytical and la …
  • SimCorp AS (SIM):企業の財務・戦略的SWOT分析
    SimCorp AS (SIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Tele2 AB (TEL2 B):企業の財務・戦略的SWOT分析
    Tele2 AB (TEL2 B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Banco Nacional de Obras y Servicios Publicos SNC:企業の戦略・SWOT・財務情報
    Banco Nacional de Obras y Servicios Publicos SNC - Strategy, SWOT and Corporate Finance Report Summary Banco Nacional de Obras y Servicios Publicos SNC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Swissgrid AG:企業の戦略的SWOT分析
    Swissgrid AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • SNC-Lavalin Group Inc (SNC)-エネルギー分野:企業M&A・提携分析
    Summary SNC-Lavalin Group Inc. (SNC) is global provider of engineering and construction services. It offers a range of engineering, procurement, construction, project management services to various industries, including oil and gas, mining and metallurgy, infrastructure and power. In addition, the c …
  • Medical Developments International Ltd (MVP):企業の財務・戦略的SWOT分析
    Summary Medical Developments International Ltd (MDI) is a healthcare company that develops, manufactures and markets pain relief and respiratory medicine. The company provides products such as penthrox, asthma and COPD, medical devices and veterinary products. It offers asthma and COPD products whic …
  • Pyxant Labs Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pyxant Labs Inc (Pyxant) is a bioanalytical laboratory that offers laboratory services. The laboratory’s services include picogram-level bioanalytical method development and validation, analytical and bioanalytical support for ADME studies, and analytical and bioanalytical support for pharma …
  • Bioneer Corp (064550):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioneer Corp (Bioneer) is a molecular diagnostic company that develops and produces molecular research and molecular diagnostic products and instruments. The company’s major molecular research products include DNA/RNA amplification pre mixes, DNA/RNA preparation system, oligo synthesis and r …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆